Literature DB >> 9675127

Fodrin inhibits phospholipases A2, C, and D by decreasing polyphosphoinositide cell content.

S Lukowski1, J P Mira, A Zachowski, B Geny.   

Abstract

Brain fodrin inhibited in a dose dependent manner the GTPgammaS-stimulated cytosolic PLA2 (cPLA2), PLC, and PLD activities in differentiated HL-60 cells permeabilized with streptolysin O. cPLA2 and PLD were inhibited by the same concentrations of fodrin (IC50=1.5-2 nM) but PLC was inhibited by lower concentrations (IC50=0.3 nM). Moreover, the rates of inhibition were different between the phospholipases. Spectrin, which shares 50% homology with fodrin, had similar effects on the three phospholipases. However, using cytosol-depleted cells or recombinant PLD1, we showed that fodrin was not a direct inhibitor. Studying the potential mechanisms of these inhibitions, we demonstrated that a major decrease in membrane phosphatidylinositol 4-monophosphate (PtdIns(4)P) and phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) amounts was induced by fodrin. Exogenous PtdIns(4,5)P2 partly reversed fodrin inhibition of GTPgammaS-stimulated phospholipase C activity. Hence, inhibition of PLC, cPLA2, and PLD activities observed with fodrin could be related to the decrease of PtdIns(4,5)P2, substrate of PLC, a cofactor of PLD and an enhancer of cPLA2 activity. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9675127     DOI: 10.1006/bbrc.1998.8942

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Cytoskeletal protein 4.1G binds to the third intracellular loop of the A1 adenosine receptor and inhibits receptor action.

Authors:  Dongcheng Lu; Henglin Yan; Timothy Othman; Christopher P Turner; Thomas Woolf; Scott A Rivkees
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

2.  Low hippocampal PI(4,5)P₂ contributes to reduced cognition in old mice as a result of loss of MARCKS.

Authors:  Laura Trovò; Tariq Ahmed; Zsuzsanna Callaerts-Vegh; Andrea Buzzi; Claudia Bagni; Marinee Chuah; Thierry Vandendriessche; Rudi D'Hooge; Detlef Balschun; Carlos G Dotti
Journal:  Nat Neurosci       Date:  2013-02-24       Impact factor: 24.884

Review 3.  Phospholipase D: molecular and cell biology of a novel gene family.

Authors:  M Liscovitch; M Czarny; G Fiucci; X Tang
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Regulation of mammalian phospholipase D2: interaction with and stimulation by G(M2) activator.

Authors:  S Sarkar; N Miwa; H Kominami; N Igarashi; S Hayashi; T Okada; S Jahangeer; S Nakamura
Journal:  Biochem J       Date:  2001-11-01       Impact factor: 3.857

Review 5.  Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.

Authors:  Wenjuan Su; Qin Chen; Michael A Frohman
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 6.  Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Authors:  Ronald C Bruntz; Craig W Lindsley; H Alex Brown
Journal:  Pharmacol Rev       Date:  2014-10       Impact factor: 25.468

Review 7.  Phospholipase D signaling: orchestration by PIP2 and small GTPases.

Authors:  Paschal A Oude Weernink; Maider López de Jesús; Martina Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-24       Impact factor: 3.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.